Healthier Diets, Lower Waist-to-Hip Ratio in Midlife Improve Later Cognitive Health
By Lori Solomon HealthDay Reporter
TUESDAY, March 18, 2025 -- Healthier diets and lower waist-to-hip ratio (WHR) throughout midlife are associated with better brain and cognitive health in older age, according to a study published online March 12 in JAMA Network Open.
Daria E.A. Jensen, D.Phil., from University of Oxford in the United Kingdom, and colleagues used data from participants in the Whitehall II Study to understand how longitudinal changes in diet quality (512 participants) and WHR (664 participants) during midlife are associated with hippocampal connectivity and cognitive function in later life.
The researchers found that better diet quality in midlife and from midlife to late life was associated with higher hippocampal functional connectivity to the occipital lobe and cerebellum and better white matter integrity as measured by higher fractional anisotropy and lower diffusivity. Furthermore, higher WHR in midlife was associated with higher mean diffusivity and radial diffusivity (covering 26.4 and 23.1 percent, respectively, of the total white matter tracts in the cingulum and superior and inferior longitudinal fasciculus) and lower fractional anisotropy in the corticospinal tract (covering 4.9 percent of the white matter skeleton), including the inferior longitudinal fasciculus and cingulum. Diffusivity partially mediated associations between midlife WHR, working memory, and executive function.
"The findings suggest that interventions to improve diet and manage central obesity might be most effective between ages 48 and 70 years," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted March 2025
Read this next
Few Adolescents With Obesity Prescribed Obesity Medications
FRIDAY, June 13, 2025 -- Despite an increase in the prevalence of prescribing, only 0.5 percent of U.S. adolescents with obesity were prescribed an obesity medication in 2023...
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...
Adherence to Healthy Diet Improves Cardiometabolic Risk, Even Without Weight Loss
WEDNESDAY, June 11, 2025 -- A healthy diet improves cardiometabolic risk factors, even if not associated with weight loss (WL), according to a study published online June 5...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.